NEW YORK (GenomeWeb) – Opko Health today said that its proposed acquisition of Bio-Reference Laboratories has passed US antitrust review.

Early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 was granted yesterday, Opko said. The deal is still subject to other closing conditions including the approval of BRL's shareholders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.